The First $100 Billion Drug
Publisher |
Barron's
Media Type |
audio
Categories Via RSS |
Business
Publication Date |
Jan 06, 2023
Episode Duration |
00:24:12
BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time. Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review